79 related articles for article (PubMed ID: 34844191)
1. Next generation plasma proteome profiling of COVID-19 patients with mild to moderate symptoms.
Zhong W; Altay O; Arif M; Edfors F; Doganay L; Mardinoglu A; Uhlen M; Fagerberg L
EBioMedicine; 2021 Dec; 74():103723. PubMed ID: 34844191
[TBL] [Abstract][Full Text] [Related]
2. In-depth blood proteome profiling analysis revealed distinct functional characteristics of plasma proteins between severe and non-severe COVID-19 patients.
Park J; Kim H; Kim SY; Kim Y; Lee JS; Dan K; Seong MW; Han D
Sci Rep; 2020 Dec; 10(1):22418. PubMed ID: 33376242
[TBL] [Abstract][Full Text] [Related]
3. Neurochemical signs of astrocytic and neuronal injury in acute COVID-19 normalizes during long-term follow-up.
Kanberg N; Simrén J; Edén A; Andersson LM; Nilsson S; Ashton NJ; Sundvall PD; Nellgård B; Blennow K; Zetterberg H; Gisslén M
EBioMedicine; 2021 Aug; 70():103512. PubMed ID: 34333238
[TBL] [Abstract][Full Text] [Related]
4. Plasma Gradient of Soluble Urokinase-Type Plasminogen Activator Receptor Is Linked to Pathogenic Plasma Proteome and Immune Transcriptome and Stratifies Outcomes in Severe COVID-19.
Sarif J; Raychaudhuri D; D'Rozario R; Bandopadhyay P; Singh P; Mehta P; Hoque MA; Sinha BP; Kushwaha M; Sahni S; Devi P; Chattopadhyay P; Paul SR; Ray Y; Chaudhuri K; Banerjee S; Majumdar D; Saha B; Sarkar BS; Bhattacharya P; Chatterjee S; Paul S; Ghosh P; Pandey R; Sengupta S; Ganguly D
Front Immunol; 2021; 12():738093. PubMed ID: 34777349
[TBL] [Abstract][Full Text] [Related]
5. Plasma Proteome Fingerprints Reveal Distinctiveness and Clinical Outcome of SARS-CoV-2 Infection.
Bauer W; Weber M; Diehl-Wiesenecker E; Galtung N; Prpic M; Somasundaram R; Tauber R; Schwenk JM; Micke P; Kappert K
Viruses; 2021 Dec; 13(12):. PubMed ID: 34960725
[TBL] [Abstract][Full Text] [Related]
6. Single-Cell Transcriptomic Profiling of MAIT Cells in Patients With COVID-19.
Shi J; Zhou J; Zhang X; Hu W; Zhao JF; Wang S; Wang FS; Zhang JY
Front Immunol; 2021; 12():700152. PubMed ID: 34394094
[TBL] [Abstract][Full Text] [Related]
7. Next generation plasma proteome profiling to monitor health and disease.
Zhong W; Edfors F; Gummesson A; Bergström G; Fagerberg L; Uhlén M
Nat Commun; 2021 May; 12(1):2493. PubMed ID: 33941778
[TBL] [Abstract][Full Text] [Related]
8. Ultra-Sensitive Serial Profiling of SARS-CoV-2 Antigens and Antibodies in Plasma to Understand Disease Progression in COVID-19 Patients with Severe Disease.
Ogata AF; Maley AM; Wu C; Gilboa T; Norman M; Lazarovits R; Mao CP; Newton G; Chang M; Nguyen K; Kamkaew M; Zhu Q; Gibson TE; Ryan ET; Charles RC; Marasco WA; Walt DR
Clin Chem; 2020 Dec; 66(12):1562-1572. PubMed ID: 32897389
[TBL] [Abstract][Full Text] [Related]
9. A blood atlas of COVID-19 defines hallmarks of disease severity and specificity.
;
Cell; 2022 Mar; 185(5):916-938.e58. PubMed ID: 35216673
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal Profiling of Antibody Response in Patients With COVID-19 in a Tertiary Care Hospital in Beijing, China.
Feng X; Yin J; Zhang J; Hu Y; Ouyang Y; Qiao S; Zhao H; Zhang T; Li X; Zhang L; Zhang J; Jin R; Feng Y; Su B
Front Immunol; 2021; 12():614436. PubMed ID: 33790892
[TBL] [Abstract][Full Text] [Related]
11. Quantitative plasma proteome profiling of COVID-19 patients with mild and moderate symptoms.
Jiang HW; Tao SC
EBioMedicine; 2022 Jan; 75():103773. PubMed ID: 34959132
[No Abstract] [Full Text] [Related]
12. Multimodal single-cell omics analysis identifies epithelium-immune cell interactions and immune vulnerability associated with sex differences in COVID-19.
Hou Y; Zhou Y; Gack MU; Lathia JD; Kallianpur A; Mehra R; Chan TA; Jung JU; Jehi L; Eng C; Cheng F
Signal Transduct Target Ther; 2021 Jul; 6(1):292. PubMed ID: 34330889
[TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2 immune repertoire in MIS-C and pediatric COVID-19.
Ravichandran S; Tang J; Grubbs G; Lee Y; Pourhashemi S; Hussaini L; Lapp SA; Jerris RC; Singh V; Chahroudi A; Anderson EJ; Rostad CA; Khurana S
Nat Immunol; 2021 Nov; 22(11):1452-1464. PubMed ID: 34611361
[TBL] [Abstract][Full Text] [Related]
14. Facets of individual-specific health signatures determined from longitudinal plasma proteome profiling.
Dodig-Crnković T; Hong MG; Thomas CE; Häussler RS; Bendes A; Dale M; Edfors F; Forsström B; Magnusson PKE; Schuppe-Koistinen I; Odeberg J; Fagerberg L; Gummesson A; Bergström G; Uhlén M; Schwenk JM
EBioMedicine; 2020 Jul; 57():102854. PubMed ID: 32629387
[TBL] [Abstract][Full Text] [Related]
15. Proteomics of extracellular vesicles in plasma reveals the characteristics and residual traces of COVID-19 patients without underlying diseases after 3 months of recovery.
Mao K; Tan Q; Ma Y; Wang S; Zhong H; Liao Y; Huang Q; Xiao W; Xia H; Tan X; Luo P; Xu J; Long D; Jin Y
Cell Death Dis; 2021 May; 12(6):541. PubMed ID: 34035220
[TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2-Specific Antibody and T Cell Response Kinetics According to Symptom Severity.
Kim JY; Kwon JS; Bae S; Cha HH; Lim JS; Kim MC; Chung JW; Park SY; Lee MJ; Kim BN; Jung J; Kim MJ; Shin EC; Kim SH
Am J Trop Med Hyg; 2021 Jun; 105(2):395-400. PubMed ID: 34143752
[TBL] [Abstract][Full Text] [Related]
17. Highly Sensitive Quantification of Plasma Severe Acute Respiratory Syndrome Coronavirus 2 RNA Sheds Light on its Potential Clinical Value.
Veyer D; Kernéis S; Poulet G; Wack M; Robillard N; Taly V; L'Honneur AS; Rozenberg F; Laurent-Puig P; Bélec L; Hadjadj J; Terrier B; Péré H
Clin Infect Dis; 2021 Nov; 73(9):e2890-e2897. PubMed ID: 32803231
[TBL] [Abstract][Full Text] [Related]
18. Proteo-Genomic Analysis of SARS-CoV-2: A Clinical Landscape of Single-Nucleotide Polymorphisms, COVID-19 Proteome, and Host Responses.
Tushir S; Kamanna S; Nath SS; Bhat A; Rose S; Aithal AR; Tatu U
J Proteome Res; 2021 Mar; 20(3):1591-1601. PubMed ID: 33555895
[TBL] [Abstract][Full Text] [Related]
19. Cytokine Profiles Associated With Worse Prognosis in a Hospitalized Peruvian COVID-19 Cohort.
Pons MJ; Ymaña B; Mayanga-Herrera A; Sáenz Y; Alvarez-Erviti L; Tapia-Rojas S; Gamarra R; Blanco AB; Moncunill G; Ugarte-Gil MF
Front Immunol; 2021; 12():700921. PubMed ID: 34539631
[TBL] [Abstract][Full Text] [Related]
20. B Cell Subsets as Severity-Associated Signatures in COVID-19 Patients.
Sosa-Hernández VA; Torres-Ruíz J; Cervantes-Díaz R; Romero-Ramírez S; Páez-Franco JC; Meza-Sánchez DE; Juárez-Vega G; Pérez-Fragoso A; Ortiz-Navarrete V; Ponce-de-León A; Llorente L; Berrón-Ruiz L; Mejía-Domínguez NR; Gómez-Martín D; Maravillas-Montero JL
Front Immunol; 2020; 11():611004. PubMed ID: 33343585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
